{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Malabsorption", "query": { "condition": "Malabsorption" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 238, "total_pages": 24, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Malabsorption&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-23T18:57:07.152Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06001177", "title": "A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Celiac Disease", "Coeliac Disease" ], "interventions": [ { "name": "KAN-101", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 55, "start_date": "2023-12-13", "completion_date": "2025-01-13", "has_results": true, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 6, "location_summary": "Colorado Springs, Colorado • Hialeah Gardens, Florida • Miami, Florida + 3 more", "locations": [ { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Hialeah Gardens", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Wichita", "state": "Kansas" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06001177" }, { "nct_id": "NCT00798967", "title": "Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Short Bowel Syndrome" ], "interventions": [ { "name": "teduglutide", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 86, "start_date": "2008-11-25", "completion_date": "2011-01-25", "has_results": true, "last_update_posted_date": "2021-06-03", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 11, "location_summary": "La Jolla, California • Washington D.C., District of Columbia • Jacksonville, Florida + 8 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00798967" }, { "nct_id": "NCT06557772", "title": "A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coeliac Disease", "Celiac Disease" ], "interventions": [ { "name": "Amlitelimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "SIGE", "type": "DIETARY_SUPPLEMENT" }, { "name": "Gluten-free product (GFP)", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 229, "start_date": "2024-08-29", "completion_date": "2029-04-10", "has_results": false, "last_update_posted_date": "2026-02-25", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 35, "location_summary": "Scottsdale, Arizona • Arcadia, California • Lancaster, California + 32 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Arcadia", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Oxnard", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06557772" }, { "nct_id": "NCT01845116", "title": "Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Total Parenteral Nutrition-induced Cholestasis" ], "interventions": [ { "name": "Omegaven®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Weeks", "maximum_age": "18 Years", "sex": "ALL", "summary": "4 Weeks to 18 Years" }, "enrollment_count": 11, "start_date": "2010-07", "completion_date": "2020-07", "has_results": true, "last_update_posted_date": "2022-11-23", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 1, "location_summary": "Charlotte, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01845116" }, { "nct_id": "NCT03866538", "title": "Budesonide in Patients With Immune Mediated Enteropathies", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Enteropathy", "Celiac Disease", "CVID Enteropathy", "Collagenous Sprue", "Autoimmune Enteropathy" ], "interventions": [ { "name": "Withdrawal of Oral Budesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2019-09-10", "completion_date": "2021-10-19", "has_results": true, "last_update_posted_date": "2022-08-26", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03866538" }, { "nct_id": "NCT00572975", "title": "Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cystic Fibrosis", "Pancreatic Insufficiency" ], "interventions": [ { "name": "Pentadecanoic acid (PA) and Triheptadecanoin (THA)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "8 Years", "maximum_age": null, "sex": "ALL", "summary": "8 Years and older" }, "enrollment_count": 9, "start_date": "2006-08", "completion_date": "2008-03", "has_results": false, "last_update_posted_date": "2008-09-30", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00572975" }, { "nct_id": "NCT03941184", "title": "Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "SCAD", "Addison Disease", "Ankylosing Spondylitis", "Antiphospholipid Antibody Syndrome", "Celiac Disease", "Crohn Disease", "Dermatomyositis", "Polymyositis", "Guillain-Barre Syndrome", "Hepatitis, Autoimmune", "Graves Disease", "Hashimoto Thyroiditis", "Multiple Sclerosis", "Myasthenia Gravis", "Pernicious Anemia", "Polymyalgia Rheumatica", "Primary Biliary Cirrhosis", "Psoriasis", "Rheumatoid Arthritis", "Systemic Sclerosis", "Sjögren Syndrome", "Systemic Lupus Erythematosus", "Takayasu Arteritis", "Type 1 Diabetes Mellitus", "Ulcerative Colitis", "Uveitis", "Vasculitis", "Vitiligo", "Raynaud" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "110 Years", "sex": "ALL", "summary": "18 Years to 110 Years" }, "enrollment_count": 114, "start_date": "1995-01-01", "completion_date": "2020-11-10", "has_results": false, "last_update_posted_date": "2020-11-23", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03941184" }, { "nct_id": "NCT03143517", "title": "Fecal Calprotectin Collection Protocol", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Inflammatory Bowel Diseases", "Irritable Bowel Syndrome", "Ulcerative Colitis", "Crohn Disease", "Indeterminate Colitis", "Chronic Diarrhea", "Celiac Disease", "Diverticulitis", "Abdominal Pain", "Distension", "Weight Loss", "Food Intolerance", "Constipation" ], "interventions": [ { "name": "Stool collection", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "DiaSorin Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 240, "start_date": "2017-04-19", "completion_date": "2018-08-23", "has_results": false, "last_update_posted_date": "2019-02-07", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 13, "location_summary": "Dothan, Alabama • Little Rock, Arkansas • Mission Hills, California + 10 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Mission Hills", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Lauderdale Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03143517" }, { "nct_id": "NCT01576003", "title": "Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bloodstream Infections", "Short Bowel Syndrome", "Development", "Nutrition", "Biological Markers" ], "interventions": [ { "name": "Glutamine", "type": "DRUG" }, { "name": "L-alanine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Months", "sex": "ALL", "summary": "6 Weeks to 12 Months" }, "enrollment_count": 10, "start_date": "2012-04", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2020-06-11", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 2, "location_summary": "Ann Arbor, Michigan • Cincinnati, Ohio", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01576003" }, { "nct_id": "NCT05650112", "title": "Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy", "Enteric Hyperoxaluria" ], "interventions": [ { "name": "FB-001", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Federation Bio Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 48, "start_date": "2022-11-16", "completion_date": "2024-08-31", "has_results": false, "last_update_posted_date": "2023-01-25", "last_synced_at": "2026-07-23T18:57:07.152Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05650112" } ] }